Knopp NeuroSciences secures license for neurodegenerative biomarkers
9th Sep 2005, 02:03 GMT
Knopp NeuroSciences has secured an exclusive license from the University of Pittsburgh to commercialize a panel of protein biomarkers as a diagnostic test for the neurodegenerative disease amyotrophic lateral sclerosis.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol